The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Clinical study and follow-up of 100 patients withthe antiphospholipid syndrome
Abstract
Objectives To study the clinical characteristics at diagnosis and during follow-up of patients with the antiphospholipid syndrome (APS) and to analyze the influence of treatment on their outcome.Patients One hundred patients with APS were included (86% female and 14% male; mean age, 36 years). Sixty-two percent had primary APS and 38% had APS associated with systemic lupus erythematosus (SLE). The median length of follow-up was 49 months.Results Fifty-three percent of the patients had thromboses, 52% had thrombocytopenia, and 60% of the women had pregnancy losses. Patients with APS associated with SLE had a higher prevalence of hemolytic anemia (P = .02), thrombocytopenia (platelet count lower than 100 x 10(9)/L) (P = .004), antinuclear antibodies (P = .0002), and low complement levels. Fifty-three percent of the patients with thrombosis had recurrent episodes (86% in the same site as the previous thrombotic event). Recurrences were observed in 19% of the episodes treated with long-term oral anticoagulation, in 42% treated prophylactically with aspirin, and in 91% in which anticoagulant/antiaggregant treatment was discontinued (P = .0007). Multivariate analysis showed that prophylactic treatment and older age had an independent predictive value for rethrombosis. Prophylactic treatment during pregnancy (usually with aspirin) increased the live birth rate from 38% to 72% (P = .0002).Conclusions Patients with APS have a high risk of recurrent thromboses. Long-term oral anticoagulation seems to be the best prophylactic treatment to prevent recurrences. Prophylactic treatment with aspirin during pregnancy reduced the rate of miscarriages remarkably.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For women with a history of fetal loss, combination treatment with LDA and heparin was associated with a higher likelihood of live birth compared with treatment with LDA alone.”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [48]
In the citing paper
“Data from two studies (one RCT, one retrospective cohort)48 55 showed that the likelihood of live births did not differ between women treated with LDA plus heparin and those treated with LDA alone.”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [48]
In the citing paper
“However, these studies included women with histories of both early and mid-pregnancy losses.48–52”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [48]
In the citing paper
“Pooled data from one RCT including only patients with a history of first trimester losses46 and eight supporting observational studies47–54 that did not exclusively study women with early pregnancy losses indicated a higher likelihood of live births with combination treatment with LDA and heparin at prophylactic dosage versus LDA alone.”
From EULAR recommendations for the management of antiphospholipid syndrome in adults (2019) · cites this paper as [48]
Citations
Cites
The 1982 revised criteria for the classification of systemic lupus erythematosus
Tan, E. M., Cohen, A. S., Fries, J. F., Masi, A. T., Mcshane, D. J., Rothfield, N. F., Schaller, J. G., Talal, N., & Winchester, R. J. (1982) · Arthritis & Rheumatism · doi:10.1002/art.1780251101 · Cited by 14,519
The management of thrombosis in the antiphospholipid-antibody syndrome
Khamashta, M. A., Cuadrado, M. J., Mujic, F., Taub, N. A., Hunt, B. J., & Hughes, G. R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504133321504 · Cited by 1,450
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Cervera, R., Khamashta, M. A., Font, J., Sebastiani, G. D., GIL, A., Lavilla, P., Domenech, I., Aydintug, A., Jędryka-Góral, A., de Ramón, E., et al. (1993) · Medicine · doi:10.1097/00005792-199303000-00005 · Cited by 976
The “Primary” Antiphospholipid Syndrome
Asherson, R. A., Khamashta, M. A., Ordi, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · Medicine · doi:10.1097/00005792-198911000-00004 · Cited by 963
The "primary" antiphospholipid syndrome: major clinical and serological features.
Asherson, R. A., Khamashta, M. A., Ordi‐Ros, J., Derksen, R. H. W. M., Machin, S. J., Barquinero, J., OUTT, H. H., Harris, E. N., Vilardell, M., & Hughes, G. R. V. (1989) · PubMed · Cited by 892
Kutteh, W. H. (1996) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(96)70610-5 · Cited by 807
Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients
Rosove, M. H., & Brewer, P. M. C. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-4-303 · Cited by 700
Anticardiolipin antibodies: isotype distribution and phospholipid specificity.
Gharavi, A. E., Harris, E. N., Asherson, R. A., & Hughes, G. R. V. (1987) · Annals of the Rheumatic Diseases · doi:10.1136/ard.46.1.1 · Cited by 641
Cowchock, F. S., Reece, E. A., Balaban, D. J., Branch, D. W., & Plouffe, L. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(92)91596-3 · Cited by 585
(1996) · PubMed · Cited by 307
Rai, R., Clifford, K., Cohen, H., & Regan, L. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135907 · Cited by 301
Immunology of the antiphospholipid antibody syndrome
Roubey, R. A. S. (1996) · Arthritis & Rheumatism · doi:10.1002/art.1780390903 · Cited by 300
Horbach, D. A., van Oort, E., Donders, R. C. J. M., Derksen, R. H. W. M., & de Groot, P. G. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650686 · Cited by 246
Antiphospholipid antibodies and fetal death
Oshiro, B. T., SILVER, R., SCOTT, J., YU, H., & WAREBRANCH, D. (1996) · Obstetrics and Gynecology · doi:10.1016/0029-7844(95)00498-x · Cited by 229
Brandt, J. T., Barna, L. K., & Triplett, D. A. (1995) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1649988 · Cited by 228
Monitoring Warfarin Therapy in Patients with Lupus Anticoagulants
Moll, S., & Ortel, T. L. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-127-3-199708010-00001 · Cited by 217
Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients
Shah, N. M., Khamashta, M. A., Atsumi, T., & Hughes, G. R. (1998) · Lupus · doi:10.1191/096120398678919624 · Cited by 204
Krnic-Barrie, S. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.157.18.2101 · Cited by 184
Wahl, D. G., Guillemin, F., de Maistre, E., Perret‐Guillaume, C., Lecompte, T., & Thibaut, G. (1998) · Lupus · doi:10.1191/096120398678919688 · Cited by 184
Clinical and serological features of the "anti-phospholipid syndrome" (APS)
Harris, E. N. (1987) · Lara D. Veeken · Cited by 177
Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation.
Sthoeger, Z. M., Mozes, E., & Tartakovsky, B. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6464 · Cited by 141
Fishman, P., Falach‐Vaknin, E., Zigelman, R., Bakimer, R., Sredni, B., Djaldetti, M., & Shoenfeld, Y. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116396 · Cited by 132
Exclusion criteria for primary antiphospholipid syndrome.
Pietté, J. C., Wechsler, B., Francès, C., Papo, T., & Godeau, P. (1993) · PubMed · Cited by 110
Hughson, M. D., Nádasdy, T., McCarty, G. A., Sholer, C., Min, K.-W., & Silva, F. (1992) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(12)80543-9 · Cited by 109
Review : Obstetric outcome in antiphospholipid syndrome
Granger, K., & Farquharson, R. G. (1997) · Lupus · doi:10.1177/096120339700600606 · Cited by 89
Forastiero, R. R., Martinuzzo, M. E., Kordich, L., & Carreras, L. O. (1996) · PubMed · Cited by 84
Antiphospholipid antibodies and antiphospholipid syndrome
Khamashta, M. A., & Hughes, G. R. V. (1995) · Current Opinion in Rheumatology · doi:10.1097/00002281-199509000-00005 · Cited by 73
Forastiero, R. R., Martinuzzo, M. E., Kordich, L., & Carreras, L. O. (1996) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1650354 · Cited by 72
Review : Serological markers of disease activity in systemic lupus erythematosus
Spronk, P. E., Limburg, P. C., & Kallenberg, C. G. M. (1995) · Lupus · doi:10.1177/096120339500400202 · Cited by 71
Hemocytopenia in systemic lupus erythematosus. Relationship to antiphospholipid antibodies.
Delezé, M., Alarcón-Segovia, D., Oria, C. V., Sánchez‐Guerrero, J., Fernández-Dominguez, L., Gómez-Pacheco, L., & de León, S. P. (1989) · PubMed · Cited by 69
Querrec, L., Delahousse, B., Caron, C., Houbouyan, L., Boutiere, B., Horellou, M., Reber, G., Siè, P., Robert, A., & la Thrombose, T. G. «. E. H. D. G. D. S. L. E. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615146 · Cited by 62
Shurtz-Swirski, R., Inbar, O., Blank, M., COHEN, J., Bakimer, R., Barnea, E. R., & Shoenfeld, Y. (1993) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1993.tb00588.x · Cited by 60
Clinicopathologic correlations of theantiphospholipid syndrome
Cervera, R., Asherson, R. A., & Lie, J. T. (1995) · Seminars in Arthritis and Rheumatism · doi:10.1016/s0049-0172(95)80036-0 · Cited by 59
Font, J., Cervera, R., López‐Soto, A., Pallarés, L., Bosch, X., Ampurdanés, S., Casals, F. J., & Ingelmo, M. (1989) · Clinical Rheumatology · doi:10.1007/bf02032099 · Cited by 58
Fabris, F., Steffan, A., Cordiano, I., Borzini, P., Luzzatto, G., Randi, M. L., & Girolami, A. (1994) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1994.tb00195.x · Cited by 50
Valle, P. D., Crippa, L., Safa, O., Tomassini, L., Pattarini, E., Vigano’D’Angelo, S., Sabbadini, M. G., & D’Angelo, A. (1996) · PubMed · Cited by 46
Antiphospholipid syndrome: patterns of life-threatening and severe recurrent vascular complications.
Insko, E. K., & Haskal, Z. J. (1997) · Radiology · doi:10.1148/radiology.202.2.9015050 · Cited by 39
Sthoeger, Z. M., Sthoeger, D., Green, L., & Geltner, D. (1993) · PubMed · Cited by 32
Jouhikainen, T., Kekomäki, R., Leirisalo‐Repo, M., Bäcklund, T., & Myllylä, G. (1990) · European Journal Of Haematology · doi:10.1111/j.1600-0609.1990.tb00385.x · Cited by 25
Clinical manifestations and management of the antiphospholipid syndrome
Derksen, R. (1996) · Lupus · doi:10.1177/096120339600500217 · Cited by 24
Cited by
Sorted by citations
Cervera, R., Piette, J., Font, J., Khamashta, M. A., Shoenfeld, Y., Camps, M. T., Jacobsen, S., Lakos, G., Tincani, A., Kontopoulou‐Griva, I., et al. (2002) · Arthritis & Rheumatism · doi:10.1002/art.10187 · Cited by 2,156
EULAR recommendations for the management of antiphospholipid syndrome in adults
Tektonidou, M. G., Andreoli, L., Limper, M., Amoura, Z., Cervera, R., Costedoat-Chalumeau, N., Cuadrado, M. J., Dörner, T., Ferrer-Oliveras, R., Hambly, K., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-215213 · Cited by 1,318
Cervera, R., Serrano, R., Pons-Estel, G. J., Ceberio-Hualde, L., Shoenfeld, Y., de Ramón, E., Buonaiuto, V, Jacobsen, S., Zeher, M. M., Tarr, T., et al. (2015) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2013-204838 · Cited by 974
Ruiz‐Irastorza, G., Crowther, M. A., Branch, W. D., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 875
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Metadata
- Authors
- Muñoz-Rodríguez, F. J., Font, J., Cervera, R., Reverter, J. C., Tàssies, D., Espinosa, G., López-Soto, A., Carmona, F., Balasch, J., Ordinas, A., & Ingelmo, M.
- Corresponding author
- Cervera, Richard
- Venue
- Seminars in Arthritis and Rheumatism
- Publisher
- Elsevier BV
- Published
- 1999-12
- Volume
- 29
- Issue
- 3
- Pages
- 182-190
- ISSN
- 0049-0172 (ISSN-L)
- OpenAlex
- W2014368662
- Cited by
- 114
- References
- 41
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 2 · 2020: 2 · 2019: 7 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 3 · 2014: 4 · 2013: 2 · 2012: 4
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Seminars in Arthritis and Rheumatism (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Rheumatology › Systemic Lupus Erythematosus Research
- Health Sciences › Medicine › Hematology › Blood Coagulation and Thrombosis Mechanisms
- Health Sciences › Medicine › Rheumatology › Vasculitis and related conditions
- Keywords
- antiphospholipid syndrome, systemic lupus erythematosus, thrombosis, recurrent thrombosis, thrombocytopenia, miscarriage, hemolytic anemia, oral anticoagulation, aspirin prophylaxis, live birth rate, antinuclear antibodies, complement levels
- MeSH terms
- Adolescent, Adult, Aged, Anticoagulants, Diagnosis, Differential, Drug Therapy, Combination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Platelet Aggregation Inhibitors, Pregnancy, Pregnancy Complications, Pregnancy Outcome, Retrospective Studies, Thrombocytopenia, Thrombosis, Antiphospholipid Syndrome, Treatment Outcome, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review